Anika Therapeutics share price today

(ANIK)

Anika Therapeutics share price is $16.31 & ₹1,385.96 as on 21 Dec 2024, 2.30 'hrs' IST

$16.31

▲

-0.02

(-0.12%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Anika Therapeutics share price in Dollar and Rupees. Guide to invest in Anika Therapeutics from India. Also see the sentimental analysis on Indian investors investing in Anika Therapeutics. Get details on the Indian mutual funds that are investing in Anika Therapeutics. Get Analyst recommendations and forecasts along with all the Anika Therapeutics's financials.

Anika Therapeutics share price movements

Today's Low: $16.07
Today's High: $17.03
$16.31
1.5%
Downside
Day's Volatility :5.67%
Upside
4.23%
52 Weeks Low: $15.83
52 Weeks High: $29.12
$16.31
2.97%
Downside
52 Weeks Volatility :45.65%
Upside
43.98%

Anika Therapeutics Returns

Period	Anika Therapeutics Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-34.81%	-11.1%	0.0%
6 Months	-37.08%	-6.0%	0.0%
1 Year	-28.46%	2.7%	0.0%
3 Years	-57.07%	0.6%	-19.7%

Anika Therapeutics Key Statistics

in dollars & INR

Previous Close	$16.33
Open	$16.15
Today's High	$17.03
Today's Low	$16.065
Market Capitalization	$238.9M
Today's Volume	$205.9K
52 Week High	$29.115
52 Week Low	$15.825
Revenue TTM	$164.2M
EBITDA	$-8.1M
Earnings Per Share (EPS)	$-6.64
Profit Margin	-59.4%
Quarterly Earnings Growth YOY	-0.5%
Return On Equity TTM	-43.31%

How to invest in Anika Therapeutics from India?

It is very easy for Indian residents to invest directly in Anika Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Anika Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Anika Therapeutics or ANIK on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Anika Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Anika Therapeutics shares which would translate to 0.052 fractional shares of Anika Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Anika Therapeutics, in just a few clicks!

Returns in Anika Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

Anika Therapeutics investment value today

Current value as on today

₹1,30,661

Returns

₹30,661

(+30.66%)

Returns from Anika Therapeutics Stock

₹28,465 (false-28.46%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Anika Therapeutics

Period: Sep 22, 2024 to Dec 21, 2024. Change in 30 Days versus previous period

Search volume for Anika Therapeutics on INDmoney from India has grown in the last 30 days as on Dec 22, 2024. 8% more investors are searching Anika Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Anika Therapeutics

Trigran Investments Inc
14.51%
BlackRock Inc
10.97%
Caligan Partners LP
9.80%
Vanguard Group Inc
5.45%
Dimensional Fund Advisors, Inc.
4.83%
Renaissance Technologies Corp
3.92%

Analyst Recommendation on Anika Therapeutics

Buy

77%Buy

22%Hold

0%Sell

Based on 9 Wall street analysts offering stock ratings for Anika Therapeutics(by analysts ranked 0 to 5 stars)

Based on 9 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Anika Therapeutics

What analysts predicted

Upside of 62.48%

Current:

$16.31

Target:

$26.50

Insights on Anika Therapeutics

Price Movement
In the last 3 months, ANIK stock has moved down by -36.0%
Decreasing Revenue
Revenue is down for the last 2 quarters, 41.92M → 38.75M (in $), with an average decrease of 7.6% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -88.0K → -29.91M (in $), with an average decrease of 33897.7% per quarter
ANIK vs HLN (1 yr)
In the last 1 year, Haleon Plc Spon Ads has given 18.3% return, outperforming this stock by 46.3%
Price to Sales
ForANIK every $1 of sales, investors are willing to pay $1.5, whereas for Haleon Plc Spon Ads, the investors are paying $4.0 for every $1 of sales.

Anika Therapeutics Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$105.6M	↓ 6.93%
Net Income	$18.7M	↓ 41.16%
Net Profit Margin	17.74%	↓ 10.31%

	FY19	Y/Y Change
Revenue	$114.6M	↑ 8.58%
Net Income	$27.2M	↑ 45.25%
Net Profit Margin	23.73%	↑ 5.99%

	FY20	Y/Y Change
Revenue	$130.5M	↑ 13.83%
Net Income	$-24.0M	↓ 188.19%
Net Profit Margin	-18.38%	↓ 42.11%

	FY21	Y/Y Change
Revenue	$147.8M	↑ 13.29%
Net Income	$4.1M	↓ 117.24%
Net Profit Margin	2.8%	↑ 21.18%

	FY22	Y/Y Change
Revenue	$156.2M	↑ 5.71%
Net Income	$-14.9M	↓ 459.43%
Net Profit Margin	-9.51%	↓ 12.31%

	FY23	Y/Y Change
Revenue	$166.7M	↑ 6.67%
Net Income	$-82.7M	↑ 456.34%
Net Profit Margin	-49.6%	↓ 40.09%

	Q2 FY23	Q/Q Change
Revenue	$44.3M	↑ 16.82%
Net Income	$-2.7M	↓ 73.52%
Net Profit Margin	-6.19%	↑ 21.1%

	Q3 FY23	Q/Q Change
Revenue	$41.5M	↓ 6.4%
Net Income	$-6.6M	↑ 139.91%
Net Profit Margin	-15.86%	↓ 9.67%

	Q4 FY23	Q/Q Change
Revenue	$43.0M	↑ 3.63%
Net Income	$-63.0M	↑ 858.03%
Net Profit Margin	-146.61%	↓ 130.75%

	Q1 FY24	Q/Q Change
Revenue	$40.5M	↓ 5.7%
Net Income	$-4.5M	↓ 92.83%
Net Profit Margin	-11.14%	↑ 135.47%

	Q2 FY24	Q/Q Change
Revenue	$41.9M	↑ 3.45%
Net Income	$-88.0K	↓ 98.05%
Net Profit Margin	-0.21%	↑ 10.93%

	Q3 FY24	Q/Q Change
Revenue	$38.8M	↓ 7.56%
Net Income	$-29.9M	↑ 33897.73%
Net Profit Margin	-77.2%	↓ 76.99%

	FY18	Y/Y Change
Profit	$74.3M	↓ 13.69%

	FY19	Y/Y Change
Profit	$85.9M	↑ 15.6%

	FY20	Y/Y Change
Profit	$69.0M	↓ 19.61%

	FY21	Y/Y Change
Profit	$82.9M	↑ 20.16%

	FY22	Y/Y Change
Profit	$93.6M	↑ 12.82%

	FY23	Y/Y Change
Profit	$103.1M	↑ 10.16%

	Q2 FY23	Q/Q Change
Profit	$29.0M	↑ 26.83%

	Q3 FY23	Q/Q Change
Profit	$24.9M	↓ 13.9%

	Q4 FY23	Q/Q Change
Profit	$26.3M	↑ 5.55%

	Q1 FY24	Q/Q Change
Profit	$24.6M	↓ 6.46%

	Q2 FY24	Q/Q Change
Profit	$27.4M	↑ 11.11%

	Q3 FY24	Q/Q Change
Profit	$1.4M	↓ 94.74%

	FY18	Y/Y Change
Operating Cash Flow	$34.9M	↓ 14.44%
Investing Cash Flow	$-50.3M	↑ 302.7%
Financing Cash Flow	$-28.9M	↓ 9305.1%

	FY19	Y/Y Change
Operating Cash Flow	$37.0M	↑ 5.98%
Investing Cash Flow	$39.7M	↓ 178.98%
Financing Cash Flow	$-8.1M	↓ 71.83%

	FY20	Y/Y Change
Operating Cash Flow	$13.1M	↓ 64.69%
Investing Cash Flow	$-71.3M	↓ 279.55%
Financing Cash Flow	$-3.8M	↓ 53.65%

	FY21	Y/Y Change
Operating Cash Flow	$8.4M	↓ 35.73%
Investing Cash Flow	$-3.1M	↓ 95.62%
Financing Cash Flow	$-6.8M	↑ 79.62%

	FY22	Y/Y Change
Operating Cash Flow	$4.4M	↓ 47.49%
Investing Cash Flow	$-7.5M	↑ 140.09%
Financing Cash Flow	$-4.9M	↓ 28.43%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-8.3M	↑ 129.22%
Investing Cash Flow	$-1.5M	↑ 4.9%
Financing Cash Flow	$-4.9M	↑ 206.45%

Anika Therapeutics Technicals Summary

Sell

Neutral

Buy

Anika Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Anika Therapeutics Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Anika Therapeutics Inc	-3.89%	-37.08%	-28.46%	-57.07%	-69.23%
Neurocrine Biosciences Inc.	7.78%	1.35%	3.22%	59.15%	24.17%
Haleon Plc Spon Ads	0.41%	12.15%	18.17%	30.77%	30.77%
Zoetis Inc.	-6.85%	-4.07%	-15.68%	-32.03%	24.01%
Viatris Inc.	-6.36%	19.58%	16.9%	-8.14%	-23.38%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Anika Therapeutics Inc	NA	NA	3.47	0.1	-0.43	-0.04	NA	12.24
Neurocrine Biosciences Inc.	35.99	35.99	0.32	6.54	0.16	0.12	NA	26.87
Haleon Plc Spon Ads	28.53	28.53	1.73	0.34	0.07	0.04	0.02	1.82
Zoetis Inc.	30.68	30.68	2.6	5.88	0.47	0.15	0.01	11.59
Viatris Inc.	224.4	NA	0.07	2.69	-0.04	0.02	0.04	16.58

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Anika Therapeutics Inc	Buy	$238.9M	-69.23%	NA	-59.4%
Neurocrine Biosciences Inc.	Buy	$13.7B	24.17%	35.99	17.21%
Haleon Plc Spon Ads	Buy	$44.1B	30.77%	28.53	10.75%
Zoetis Inc.	Buy	$73.8B	24.01%	30.68	26.55%
Viatris Inc.	Hold	$14.5B	-23.38%	224.4	-5.87%

About Anika Therapeutics

who we are we are anika therapeutics, a global medical technology company at the forefront of pain management, tissue regeneration and wound healing. we are committed to delivering innovative medical solutions that help patients feel better faster, look and feel younger and remain active. with over 7 million procedures performed over the past twenty years utilizing our proprietary technology, anika is helping individuals all over the world return to life naturally. our guiding principles we are innovators and creators. we value strong discipline and exceptional focus from our personnel, and we employ lean principles and agile processes in managing our business. this foundation of guiding values, combined with our entrepreneurial spirit, gives anika the ability and fortitude to generate innovative ideas and to grow our portfolio of successful products. what we do anika offers a broad spectrum of therapeutic treatments ranging from pain management and tissue regeneration to wound care an

Organization	Anika Therapeutics
Employees	357
CEO	Dr. Cheryl Renee Blanchard Ph.D.
Industry	Health Technology

Management People of Anika Therapeutics

Name	Title
Dr. Cheryl Renee Blanchard Ph.D.	President, CEO & Director
Ms. Anne Nunes	Senior VP & COO
Mr. David Colleran J.D.	Executive VP, General Counsel & Corporate Secretary
Mr. Michael L. Levitz CPA	Executive Officer
Mr. Stephen D. Griffin	Executive VP, CFO & Treasurer
Mr. Ian W. McLeod	VP & Chief Accounting Officer
Mr. Mark Namaroff	Vice President of Investor Relations, ESG & Corporate Communications
Mr. James Chase	Senior Vice President of International Sales & Marketing
Mr. Ben Joseph	Vice President of Commercial & Corporate Development
Ms. Lisa Funiciello	Vice President of Human Resources

Important FAQs about investing in Anika Therapeutics from India :

What is Anika Therapeutics share price today?

Anika Therapeutics share price today stands at $16.31, Open: $16.15 ; Previous Close: $16.33 ; High: $17.03 ; Low: $16.07 ; 52 Week High: $29.12 ; 52 Week Low: $15.83. The stock opens at $16.15, after a previous close of $16.33. The stock reached a daily high of $17.03 and a low of $16.07, with a 52-week high of $29.12 and a 52-week low of $15.83.

Can Indians buy Anika Therapeutics shares?

Yes, Indians can invest in the Anika Therapeutics (ANIK) from India.

With INDmoney, you can buy Anika Therapeutics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Anika Therapeutics at zero transaction cost.

How can I buy Anika Therapeutics shares from India?

It is very easy to buy Anika Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Anika Therapeutics be purchased?

Yes, you can buy fractional shares of Anika Therapeutics with INDmoney app.

What are the documents required to start investing in Anika Therapeutics stocks?

To start investing in Anika Therapeutics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.